Stephen V Liu, MD· @StephenVLiu · X·· 2026-04-20Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
zoldonrasib and VS-7375 in G12D remain Phase 1 — strong numbers, small samples, not head-to-head.
Body
#AACR26 Zoldonrasib is a clean drug - toxicity profile is reassuring, with nausea, vomiting, and diarrhea seen but typically low grade, only 5% discontinuation rates due to toxicity.
Heat 10 · 9 likes · 1 reply · 0 reposts
Source: Stephen V Liu, MD · x.com